Category Archives: Our research

Influencing the reporting of ADRs in Primary Care (ISOP 2012)

Our group is very keen to improve the reporting ADRs by primary care physicians. To this end we set up an experiment to try an increase the number of Yellow Cards in the West Midlands area of the UK. You … Continue reading

Posted in Our research | Comments Off

Angioedema and angiotensin-II receptor blockers

Angioedema is a rare serious adverse drug reaction (ADR) to angiotensin-converting enzyme inhibitors (ACE-I), with an incidence of 0.1% to 1.0%. If untreated it can be life-threatening. Debate exists over the safety of switching to an angiotensin-II receptor blocker (ARB), … Continue reading

Posted in ADRs, Our research | Comments Off

Recent Research Findings

The following are three posters this unit recently presented at ISOP 2007 in October of this year: Cox AR, Anton C, Marriott JF, Ferner RE. The paradox of low prescribers who are high reporters: correlates of spontaneous reporting of adverse … Continue reading

Posted in Our research | Comments Off

ISOP 2006

The Yellow Card Centre West Midlands staff attended the 6th annual conference of the International Society of Pharmacovigilance in Liege, Belgium. We displayed three research posters and delivered an oral presentation on a variety of subjects related to drug safety. … Continue reading

Posted in Our research | Comments Off

Chief Pharmacists' views of Adverse Drug Reaction Reporting.

You can now download a PDF version of our poster presented at the International Society of Pharmacovigilance (ISOP) Annual Meeting in Dublin: Message from the top: Chief Pharmacists’ views of Adverse Drug Reaction Reporting. Anthony Cox presents the poster at … Continue reading

Posted in Our research, Yellow Card Scheme | Comments Off